Quantcast
Last updated on April 17, 2014 at 17:30 EDT

Latest Connective tissue diseases Stories

2011-09-22 07:30:00

GAITHERSBURG, Md., Sept. 22, 2011 /PRNewswire/ --The HealthWell Foundation,(®) a nonprofit organization providing financial assistance to insured patients facing a variety of chronic and life-altering illnesses, announces the launch of a new fund supporting treatment for Systemic Lupus Erythematosus (SLE), the most common form of lupus. The fund provides copayment assistance to people living with lupus who are burdened by high-cost medications. The Lupus Foundation of...

2011-09-19 14:15:00

The LRI expresses its appreciation for the inclusion of lupus in the Peer Reviewed Medical Research Program New York, NY (PRWEB) September 19, 2011 The Lupus Research Institute (LRI) expresses its appreciation for the inclusion of lupus in the Peer Reviewed Medical Research Program outlined in the U.S. Senate Defense Appropriations bill for Fiscal Year 2012, approved by the Appropriations Committee September 15. The Appropriations Committee provides $50 million in the bill for the peer...

2011-09-16 20:08:00

GERMAN TOWN, Md., Sept. 16, 2011 /PRNewswire/ -- With a patient's own adult stem cells, there is new hope for the intractable autoimmune disease lupus - systemic lupus erythematosus (SLE) - which is difficult to cure. RNL BIO's research team led by Dr. Jeong-Chan Ra collaborated with a research institute led by Dr. Eun-Hwa Choi from Samsung Bioscience Research Institute of Samsung Medical Center on a study on lupus using fat-derived stem cells. Through this study, it was confirmed that...

2011-09-16 10:45:00

EAST HANOVER, N.J., Sept. 16, 2011 /PRNewswire/ -- Novartis announced today positive results of the first pivotal Phase III trial of ACZ885 in patients with systemic juvenile idiopathic arthritis (SJIA), a rare and serious childhood auto-inflammatory disease[3]. The results, presented at the 2011 European Pediatric Rheumatology Congress in Bruges, Belgium, showed all primary and secondary endpoints of the study were met[2]. Most ACZ885 patients (83.7%) experienced at least a 30%...

2011-09-15 10:00:00

SAN FRANCISCO, Sept. 15, 2011 /PRNewswire/ -- Approximately 200 cyclists will kick off the Arthritis Foundation's 11th annual Amgen California Coast Classic Bike Tour on Saturday, September 17, in San Francisco. Participants, who will cycle down the California coastline over eight days, aim to raise more than $1.0 million this year for the Arthritis Foundation. Once again, they will finish in Santa Monica at the Yahoo! Center on Saturday, September 24, after covering 525 miles. "Since...

2011-09-14 12:02:00

BRISBANE, Calif., Sept. 14, 2011 /PRNewswire/ -- SARcode Bioscience, Inc., a privately-held biopharmaceutical company, announced today that the initial patient has been enrolled in the company's pivotal Phase 3 clinical study (OPUS-1) of SAR 1118 ophthalmic solution. (Logo: http://photos.prnewswire.com/prnh/20110718/FL36481LOGO ) SAR 1118 is a first-in-class molecule that inhibits T-cell inflammation by blocking the binding of two key cellular surface proteins (LFA-1 and ICAM-1) that...

2011-09-12 14:15:48

Research points to need for more aggressive approach to secondary prevention of cardiovascular disease in psoriasis patients Heart attack patients with psoriasis are 26 per cent more likely to die from cardiovascular disease, or suffer from recurrent heart attacks or strokes, and are 18 per cent more likely to die from all causes than those without the inflammatory skin disease. That's the key finding of a Danish study published in the September issue of the Journal of Internal Medicine....

2011-09-12 07:00:00

Two Free Canadian Apps, ArthritisID and ArthritisID PRO Now Available on iTunes Canadian arthritis research centre and arthritis patient advocacy group collaborate to develop most comprehensive health apps available for consumers and healthcare professionals To view the Enriched Media Release, click here: http://smr.newswire.ca/en/national-arthritis-awareness-program/arthritis-month-goes-mobile VANCOUVER, Sept. 12, 2011 /PRNewswire/ - Just in time for Arthritis Month in...

2011-09-09 15:30:00

HORSHAM, Pa., Sept. 9, 2011 /PRNewswire/ -- Janssen Biotech, Inc. announced today that the U.S. Food and Drug Administration (FDA) issued a Complete Response letter for the SIMPONI® (golimumab) supplemental Biologics License Application (sBLA) seeking an expanded label in the treatment of active psoriatic arthritis. The application, filed in November 2010, included data from a Phase 3 trial evaluating the effect of SIMPONI® in inhibiting the progression...

2011-09-02 18:15:00

Episode highlights the importance for men and their physicians to consider lupus diagnosis New York, NY (PRWEB) September 02, 2011 Lupus Research Institute (LRI) commends the producers of the popular television show House for once again raising the topic of lupus in men with the opening episode of its eighth season. Lupus diagnosis and misdiagnosis has been a recurring theme on the show with the star, Dr. Gregory House, often scolding his staff with the phrase...